These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 15469196)

  • 61. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
    Meador-Woodruff JH; Davis KL; Haroutunian V
    Neuropsychopharmacology; 2001 May; 24(5):545-52. PubMed ID: 11282254
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurochemical studies of schizophrenia in Japan.
    Otsuki S; Akiyama K
    Psychiatry Clin Neurosci; 1997 Dec; 51(6):347-56. PubMed ID: 9472117
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Abnormal microstructures of the basal ganglia in schizophrenia revealed by diffusion tensor imaging.
    Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Noguchi H; Nakabayashi T; Hori H; Harada S; Kunugi H; Saitoh O; Ohnishi T
    World J Biol Psychiatry; 2009; 10(1):65-9. PubMed ID: 19253093
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thalamo-cortical functional connectivity in schizophrenia and bipolar disorder.
    Skåtun KC; Kaufmann T; Brandt CL; Doan NT; Alnæs D; Tønnesen S; Biele G; Vaskinn A; Melle I; Agartz I; Andreassen OA; Westlye LT
    Brain Imaging Behav; 2018 Jun; 12(3):640-652. PubMed ID: 28444556
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The glutamate hypothesis of schizophrenia: neuroimaging and drug development.
    Egerton A; Stone JM
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1500-12. PubMed ID: 22283750
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models.
    Kantrowitz JT; Javitt DC
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):189-200. PubMed ID: 20880830
    [TBL] [Abstract][Full Text] [Related]  

  • 67. On localizing schizophrenic neuropathology.
    Weinberger DR
    Schizophr Bull; 1997; 23(3):537-40. PubMed ID: 9327520
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathological glutamatergic neurotransmission in Gilles de la Tourette syndrome.
    Kanaan AS; Gerasch S; García-García I; Lampe L; Pampel A; Anwander A; Near J; Möller HE; Müller-Vahl K
    Brain; 2017 Jan; 140(1):218-234. PubMed ID: 28007998
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hippocampal neurons in schizophrenia.
    Heckers S; Konradi C
    J Neural Transm (Vienna); 2002 May; 109(5-6):891-905. PubMed ID: 12111476
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.
    Sodhi MS; Simmons M; McCullumsmith R; Haroutunian V; Meador-Woodruff JH
    Biol Psychiatry; 2011 Oct; 70(7):646-54. PubMed ID: 21549355
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional and anatomical aspects of prefrontal pathology in schizophrenia.
    Goldman-Rakic PS; Selemon LD
    Schizophr Bull; 1997; 23(3):437-58. PubMed ID: 9327508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
    de Almeida J; Mengod G
    Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Association between the Thalamus and Social Function in Schizophrenia].
    Koshiyama D; Kasai K
    Brain Nerve; 2019 Feb; 71(2):155-160. PubMed ID: 30718444
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Altered Gradients of Glutamate and Gamma-Aminobutyric Acid Transcripts in the Cortical Visuospatial Working Memory Network in Schizophrenia.
    Hoftman GD; Dienel SJ; Bazmi HH; Zhang Y; Chen K; Lewis DA
    Biol Psychiatry; 2018 Apr; 83(8):670-679. PubMed ID: 29357982
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.
    Andreasen NC; Arndt S; Swayze V; Cizadlo T; Flaum M; O'Leary D; Ehrhardt JC; Yuh WT
    Science; 1994 Oct; 266(5183):294-8. PubMed ID: 7939669
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.
    Kegeles LS; Shungu DC; Anjilvel S; Chan S; Ellis SP; Xanthopoulos E; Malaspina D; Gorman JM; Mann JJ; Laruelle M; Kaufmann CA
    Psychiatry Res; 2000 May; 98(3):163-75. PubMed ID: 10821999
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Volumetric abnormalities in connectivity-based subregions of the thalamus in patients with chronic schizophrenia.
    Kim JJ; Kim DJ; Kim TG; Seok JH; Chun JW; Oh MK; Park HJ
    Schizophr Res; 2007 Dec; 97(1-3):226-35. PubMed ID: 17913465
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications.
    Carlsson A; Hansson LO; Waters N; Carlsson ML
    Life Sci; 1997; 61(2):75-94. PubMed ID: 9217267
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study.
    Gan JL; Cheng ZX; Duan HF; Yang JM; Zhu XQ; Gao CY
    Psychiatry Res; 2014 Jul; 223(1):23-7. PubMed ID: 24831926
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.
    Lewis DA; Volk DW; Hashimoto T
    Psychopharmacology (Berl); 2004 Jun; 174(1):143-50. PubMed ID: 15205885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.